TLDR
- ARK sold 46,015 shares of Twist Bioscience price $5.8 million thru its ARKK ETF
- ARK additionally sold shares in 10X Genomics, Bullish, Tempus AI, and Alphabet
- ARK sold $27.9 million of Meta Platforms inventory real thru two funds on September 9
- Rocket Lab shares are down almost 60% from highs; ARK sold around $forty five million price between August 31 and September 8
- ARK continues to amass Intellia Therapeutics, shopping for almost 115,000 shares
Cathie Wood’s ARK Invest made a string of trades on Friday, 11th of September, 2026, promoting a complete lot of positions while doubling down on companies tied to artificial intelligence and the dwelling economy.
The greatest sale became 46,015 shares of Twist Bioscience thru the ARKK ETF, price around $5.8 million. ARK has been slicing this notify for a complete lot of weeks.
ARK additionally sold 60,556 shares of 10X Genomics for approximately $4 million, and 121,217 shares of Bullish for roughly $4.1 million. Smaller sales incorporated Tempus AI, GeneDx Holdings, and Alphabet.
On the shopping for aspect, ARK picked up almost 115,000 shares of Intellia Therapeutics, price around $1.4 million. This continues a pattern of regular accumulation within the gene-editing firm over the past week.
ARK Bets Spacious on Meta
Two ARK funds sold a mixed $27.9 million of Meta Platforms inventory on September 9. Meta shares are currently trading about 18% beneath their all-time excessive.
ARK’s review crew capabilities to Meta’s 3.6 billion on each day foundation app users as a salvage wait on. The firm is the exercise of AI to enhance ad targeting and recommendations real thru its apps.
Meta reported second-quarter income development of 28% year over year. CEO Ticket Zuckerberg acknowledged Meta’s ad alternate is rising faster than any assorted firm’s reported ad alternate on a dollar foundation.
Meta plans to use between $165 billion and $169 billion on capital expenditures in 2026. Wood appears to be like to bear in mind those investments will generate larger free money drift over time. The inventory trades at a forward build-to-earnings extra than one in all 21.
ARK Hundreds Up on Rocket Lab
Three ARK ETFs sold around $forty five million of Rocket Lab shares between August 31 and September 8. The inventory has fallen almost 60% from its all-time excessive of $151 situation earlier this year.
Rocket Lab reported a 62% year-over-year income amplify within the second quarter, with a document backlog of $2.36 billion. The firm signed $437 million in new bookings since March 31.
CEO Peter Beck described search files from for birth services as “hideous.” Management effectively-known that birth booking slots past 2029 are “extraordinarily little,” which may per chance well well per chance wait on the firm as search files from grows.
Rocket Lab is additionally shopping Iridium, which operates 66 satellites and has over 2.5 million subscribers. Wood appears to be like to be positioning Rocket Lab as a long-interval of time dwelling infrastructure play.
ARK’s flagship ARKK ETF is up about 9% in 2026, lagging the broader market. Four assorted ARK funds personal outperformed the S&P 500 over the past three years.
ARK’s most contemporary buys repeat a transparent focal level on AI-pushed platforms and residential infrastructure heading into the final quarter of 2026.
Rupture guessing and birth investing with self assurance. KnockoutStocks presents you the AI insights, market intelligence, and inventory review you wish to space opportunities, cut thru the noise, and include smarter funding choices — all in one indispensable platform.
Enroll this day and procure 50% OFF fleshy procure real of entry to to our top fee inventory picks.
Merely exercise coupon code SPECIAL50 at checkout to assert your peculiar cut price.
